팝업레이어 알림
Plumbline Life Sciences Officially Introduced New Drug
‘Renudog’ at College of Veterinary Medicine, Seoul National University.
On April 23, 2025, Plumbline Life Sciences officially introduced its new drug
‘Renudog’ at College of Veterinary Medicine, Seoul National University.
Renudog is the world’s first (first-in-class) veterinary DNA medicine
developed to target aging itself as a disease in companion dogs.
Its primary goal is to restore reduced activity, appetite,
and immunity caused by aging in senior dogs.
Plumbline Animal DNA medicines aims to unlock the full potential of global animal medicine by delivering a new class of nucleic acid-based DNA animal medicine.
DNA medicine is highly potent and safe, like mRNA medicine, and it will remain stable at room temperature for more than a year. Also, the manufacturing process of DNA plasmid is relatively simple, as it does not require the encapsulation process.
Plumbline is applying this DNA medicine platform technology to develop both companion animal therapeutics and farm animal vaccines.
